Retraction
Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma
Paper Information
Record ID:
8134
Journal:
Publication Date:
January 16, 2017
Retraction Date:
March 07, 2017
(8.7 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Tumor Immunology Laboratory, IdiPAZ, Madrid, Spain
- Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain
- Center for Biomedical Research Network, CIBEres, Madrid, Spain
- Lymphoma Unit, Oncohealth Institute and Health Research Institute IIS-FJS-Autonomous University of Madrid, Madrid, Spain
- START Madrid FJD, Phase 1 Clinical Trials Unit, Foundation Jiménez Díaz University Hospital, Madrid, Spain
Country:
🇪🇸 SpainArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/10428194.2017.1299963Citations (2)
2
Total Citations2
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
2
After 2+ years
1192
Days since retraction (latest)
Paper citing Thalidomide analog CC-122 induces a refractory sta...
Unknown Authors
Unknown Journal
Published: Jun 2020
1192 days after retraction
Paper citing Thalidomide analog CC-122 induces a refractory sta...
Unknown Authors
Unknown Journal
Published: Dec 2019
1029 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
8.7 years
Open Access:
Yes
Last Checked:
Never